{
  "url": "https://openlegislation.uk/misuse-of-drugs-designation-order-2001/schedule/paragraph-1",
  "json_url": "https://openlegislation.uk/misuse-of-drugs-designation-order-2001/schedule/paragraph-1.json",
  "legislation": "uksi/2001/3997",
  "legislation_title": "The Misuse of Drugs (Designation) Order 2001",
  "legislation_url": "https://openlegislation.uk/misuse-of-drugs-designation-order-2001",
  "path": "schedule/paragraph/1",
  "kind": "paragraph",
  "number": "1",
  "heading": null,
  "text": "The following substances and products, namely:—\n(a) Bufotenine\nMescaline\nCannabinol\nMethcathinone\nCannabinol derivatives not being dronabinol or its stereoisomers\nPsilocin\nRaw opium\nCannabis\nRolicyclidine\nCannabis resin\nTenocyclidine\nCathinone\n4-Bromo-2,5-dimethoxy-α-methylphenethylamine\nCoca leaf\nConcentrate of poppy-straw\nN,N-Diethyltryptamine\nEticyclidine\nN,N-Dimethyltryptamine\nEtryptamine\n2,5-Dimethoxy-α,4-dimethyl-phenethylamine\nLysergamide\nLysergide and other N-alkyl derivatives of lysergamide\nN-Hydroxy-tenamphetamine\n4-Methyl-aminorex;\n(b) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;\n(c) the following phenethylamine derivatives, namely—\nAllyl(α-methyl-3,4-methylenedioxyphenethyl)amine\n2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol\n2-Amino-1-(3,4-dimethoxyphenyl)ethanol\nBenzyl(α-methyl-3,4-methylenedioxyphenethyl)amine\n4-Bromo-β,2,5-trimethoxyphenethylamine\nN-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine\nCyclopropylmethyl(α-methyl-3,4-methylenedioxyphenethyl)amine\n2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)ethylamine\n2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)-1-methylethylamine\n2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine\n2-(1,4-Dimethoxy-2-naphthyl)ethylamine\n2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine\nN-(2,5-Dimethoxy-4-propylthiophenethyl)hydroxylamine\n2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine\n2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine\nα,α-Dimethyl-3,4-methylenedioxyphenethylamine\nα,α-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine\nDimethyl(α-methyl-3,4-methylenedioxyphenethyl)amine\nN-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine\n4-Iodo-2,5-dimethoxy-α-methylphenethyl(dimethyl)amine\n2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine\n2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine\n2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine\n2-Methoxyethyl(α-methyl-3,4-methylenedioxyphenethyl)amine\n2-(5-Methoxy-2-methyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine\nβ-Methoxy-3,4-methylenedioxyphenethylamine\n1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine\n1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine\n2-(α-Methyl-3,4-methylenedioxyphenethylamino)ethanol\nα-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine\nN-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine\nO-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine\nα-Methyl-4-(methylthio)phenethylamine\nβ,3,4,5-Tetramethoxyphenethylamine\nβ,2,5-Trimethoxy-4-methylphenethylamine;\n(d) any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine, an N-alkylphenethylamine, α-methylphenethylamine, an N-alkyl-α-methylphenethylamine, α-ethylphenethylamine, or an N-alkyl-α-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substitutents, whether or not further substituted in the ring by one or more other univalent substitutents;\n(e) any compound (not being a compound for the time being specified in Part II of this Schedule) structurally derived from fentanyl by modification in any of the following ways, that is to say—\n(i) by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;\n(ii) by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;\n(iii) by substitution in the piperidine ring with alkyl or alkenyl groups;\n(iv) by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups;\n(v) by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;\n(vi) by replacement of the N-propionyl group by another acyl group;\n(f) any compound (not being a compound for the time being specified in Part II of this Schedule) structurally derived from pethidine by modification in any of the following ways, that is to say—\n(i) by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;\n(ii) by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;\n(iii) by substitution in the 4-phenyl ring with alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;\n(iv) by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;\n(v) by formation of an N-oxide or of a quaternary base.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [
    {
      "type": "inserted",
      "affecting": "uksi/2010/1800",
      "affecting_title": "The Misuse of Drugs (Designation) (Amendment No.2) (England, Wales and Scotland) Order 2010"
    },
    {
      "type": "words inserted",
      "affecting": "uksi/2010/1143",
      "affecting_title": "The Misuse of Drugs (Designation) (Amendment) (England, Wales and Scotland) Order 2010"
    },
    {
      "type": "inserted",
      "affecting": "uksi/2010/1143",
      "affecting_title": "The Misuse of Drugs (Designation) (Amendment) (England, Wales and Scotland) Order 2010"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2001/3997/schedule/paragraph/1",
    "retrieved_at": "2026-10-29T07:18:48.234026+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}